Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors.
暂无分享,去创建一个
[1] Lei Xu,et al. Pancreas Microenvironment Promotes VEGF Expression and Tumor Growth: Novel Window Models for Pancreatic Tumor Angiogenesis and Microcirculation , 2001, Laboratory Investigation.
[2] I. Fidler,et al. Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment. , 2001, Journal of the National Cancer Institute.
[3] R. B. Campbell,et al. Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Jain. Delivery of molecular and cellular medicine to solid tumors. , 2001, Advanced drug delivery reviews.
[5] John N. Hutchinson,et al. Transgenic mouse models of human breast cancer , 2000, Oncogene.
[6] A. Schally,et al. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] Thomas N. Sato,et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.
[8] R. Jain,et al. Changes in vascularization of human breast cancer xenografts responding to antiestrogen therapy. , 1999, Neoplasia.
[9] R K Jain,et al. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. , 1999, Cancer research.
[10] Anthony J. Guidi,et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] J. Ni,et al. Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Kumar,et al. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. , 1999, Cancer research.
[13] W. Cavenee,et al. Host microvasculature influence on tumor vascular morphology and endothelial gene expression. , 1998, The American journal of pathology.
[14] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[15] R K Jain,et al. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. , 1997, The American journal of pathology.
[16] R. Jain,et al. Delivery of Molecular and Cellular Medicine to Solid Tumors , 1997, Advanced drug delivery reviews.
[17] R K Jain,et al. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. , 1996, The American journal of pathology.
[18] I. Fidler,et al. Modulation of the organ microenvironment for treatment of cancer metastasis. , 1995, Journal of the National Cancer Institute.
[19] A. Harris,et al. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. , 1995, Journal of the National Cancer Institute.
[20] R K Jain,et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.
[21] R. Jain,et al. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. , 1993, Microvascular research.
[22] R. Jain,et al. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. , 1992, Cancer research.
[23] J. Price,et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. , 1990, Cancer research.
[24] J F Gross,et al. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. , 1989, International journal of radiation oncology, biology, physics.
[25] G. Hortobagyi,et al. Clinical course of breast cancer patients with liver metastases. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Posner,et al. Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. , 1974, Archives of neurology.
[27] R. Jain,et al. Transparent Window Models and Intravital Microscopy , 2002 .
[28] 武志 五本木. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth : involvement of transforming growth factor β1 , 2001 .
[29] R. Jain. The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors. , 1997, Microcirculation.
[30] M. Dellian,et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factoryvascular permeability factor antibody (angiogenesisyvascular obstruction) , 1996 .
[31] J. Folkman. Tumor angiogenesis. , 1985, Advances in cancer research.
[32] P. C. Johnson. Landis Award Lecture. The myogenic response and the microcirculation. , 1977, Microvascular research.
[33] J. Posner,et al. Leptomeningeal metastasis from systemic cancer: a report of 47 cases. , 1971, Transactions of the American Neurological Association.